ALCAR — Carmat SA Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapSucker Stock
- €162.28m
- €166.21m
- €0.35m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.85 | ||
| Price to Tang. Book | 9.85 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 470.38 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -71.09% | ||
| Return on Equity | -615.82% | ||
| Operating Margin | -15042.03% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | 2.23 | 0.34 | 12.16 | 31.24 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.
Directors
- Jean-Pierre Garnier CHM (73)
- Stephane Piat CEO (50)
- Pascale d'Arbonneau CFO
- Eric Richez DSL
- Francesco Arecchi OTH
- Raouia Bouyanzer OTH
- Thierry Dupoux OTH
- Alexandre Eleonore OTH
- Marc Grimme OTH
- Petrus Jansen OTH
- Christian Latremouille OTH
- Ivo Simundic OTH
- Karl Hennessee DRC (47)
- Philippe Pouletty DRC (64)
- Pierre Bastid IND (67)
- Henri Lachmann IND (83)
- Jean-Luc Lemercier IND (64)
- Antonino Ligresti IND (84)
- Michael Mack IND (74)
- Andre Muller IND (58)
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- June 25th, 2008
- Public Since
- July 7th, 2010
- No. of Employees
- 179
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 22,633,176
- Address
- 36, VELIZY VILLACOUBLAY, 78140
- Web
- https://www.carmatsa.com/
- Phone
- +33 139456450
- Contact
- Pascale D'arbonneau
- Auditors
- PricewaterhouseCoopers
Upcoming Events for ALCAR
Similar to ALCAR
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
FAQ
What is the Carmat SA share price?
As of Today at 13:04 UTC, shares in Carmat SA are trading at €7.17. This share price information is delayed by 15 minutes.
How has the Carmat SA share price performed this year?
Shares in Carmat SA last closed at €7.17 and the price had moved by -38.08% over the past 365 days. In terms of relative price strength the Carmat SA share price has underperformed the FTSE Global All Cap Index by -41.1% over the past year.
What are the analyst and broker recommendations for Carmat SA?
The overall consensus recommendation for Carmat SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Carmat SA dividend yield?
Carmat SA does not currently pay a dividend.
Does Carmat SA pay a dividend?
Carmat SA does not currently pay a dividend.
When does Carmat SA next pay dividends?
Carmat SA does not currently pay a dividend.
How do I buy Carmat SA shares?
To buy shares in Carmat SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Carmat SA?
As of the previous close price of €7.17, shares in Carmat SA had a market capitalisation of €162.28m.
Where are Carmat SA shares listed?
Here are the trading details for Carmat SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALCAR
What kind of share is Carmat SA?
Based on an overall assessment of its quality, value and momentum Carmat SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Carmat SA share price forecast for 2023?
The analyst consensus target price for shares in Carmat SA is €25.20. That is 251.46% above the last closing price of €7.17.
Analysts covering Carmat SA currently have a consensus Earnings Per Share (EPS) forecast of -€1.91 for the next financial year.
What is the trend in the Carmat SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carmat SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -54.33%.
As of the last closing price of €7.17, shares in Carmat SA were trading -34.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Carmat SA PE Ratio?
The Carmat SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €7.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Carmat SA?
Carmat SA's management team is headed by:
- Jean-Pierre Garnier - CHM
- Stephane Piat - CEO
- Pascale d'Arbonneau - CFO
- Eric Richez - DSL
- Francesco Arecchi - OTH
- Raouia Bouyanzer - OTH
- Thierry Dupoux - OTH
- Alexandre Eleonore - OTH
- Marc Grimme - OTH
- Petrus Jansen - OTH
- Christian Latremouille - OTH
- Ivo Simundic - OTH
- Karl Hennessee - DRC
- Philippe Pouletty - DRC
- Pierre Bastid - IND
- Henri Lachmann - IND
- Jean-Luc Lemercier - IND
- Antonino Ligresti - IND
- Michael Mack - IND
- Andre Muller - IND